U
About
UNDBIO is a pharmaceutical company that handles insulin, insulin analogues, monoclonal antibodies, general injectables, and related medical device products. Its headquarters are in Uijeongbu-si, Gyeonggi-do, and its research institute is in Suwon-si, Gyeonggi-do.
Services
Drug Device Combination
It carries out co-package development with medical device products such as insulin pumps and continuous glucose monitoring systems.
Monoclonal antibody (mAb)
It handles monoclonal antibody products such as adalimumab and bevacizumab.
Capabilities
- Assays and studies
- Efficacy research
- Analytical method development
- Quality control testing
- Quality assurance management
- Therapeutic areas
- Diabetes
- Cancer
- Immune-related intractable diseases
- Anticancer drugs
- Genetic rare diseases
Modalities and species
- Modalities
- Antibody
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: global GMP-certified pharmaceutical facilities
Company
- Type
- CDMO
- Quality
- 글로벌 GMP (Maintenance and management of the quality management system) · GMP (global GMP-certified pharmaceutical facilities)
Locations
- Based in
- Gyeonggi, South Korea
- Sites
- 의정부시, 대한민국
- 수원시, 대한민국
- Serves
- Domestic, Overseas, All low-development countries worldwide
Contacts
- Phone
- 031-853-6409